Benitec Biopharma Inc. (BNTC) Operating income 2019–2026
Benitec Biopharma Inc. (BNTC) annual operating income history from SEC filings — each fiscal year as reported.
-$51.2MFY2026 · since FY2019: $2.6M → -$51.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$51.2M | -22.6% |
| FY2025 | -$41.8M | -85.7% |
| FY2024 | -$22.5M | -17.9% |
| FY2023 | -$19.1M | -6.9% |
| FY2022 | -$17.9M | -31.3% |
| FY2021 | -$13.6M | -64.2% |
| FY2020 | -$8.3M | -420.6% |
| FY2019 | $2.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice